Moderna Tumbles After Nonpartisan Pledge, First Sell Rating

(Bloomberg) -- Moderna Inc. fell 13% on Tuesday after regulators and top drugmakers promised the Covid-19 vaccine approval process would be immune from political pressure and the biotech company dr...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.